255 related articles for article (PubMed ID: 31440027)
21. A novel mutation of
Han XY; Zhang LQ; Tang JY; Huang LZ; Tang R; Qu JF
Int J Ophthalmol; 2022; 15(6):940-946. PubMed ID: 35814885
[TBL] [Abstract][Full Text] [Related]
22. Bietti crystalline corneoretinal dystrophy associated with CYP4V2 gene mutations.
Nakamura M; Lin J; Nishiguchi K; Kondo M; Sugita J; Miyake Y
Adv Exp Med Biol; 2006; 572():49-53. PubMed ID: 17249554
[TBL] [Abstract][Full Text] [Related]
23. AAV-mediated gene-replacement therapy restores viability of BCD patient iPSC derived RPE cells and vision of Cyp4v3 knockout mice.
Jia R; Meng X; Chen S; Zhang F; Du J; Liu X; Yang L
Hum Mol Genet; 2023 Jan; 32(1):122-138. PubMed ID: 35925866
[TBL] [Abstract][Full Text] [Related]
24. Identification of CYP4V2 mutation in 36 Chinese families with Bietti crystalline corneoretinal dystrophy.
Yin X; Yang L; Chen N; Cui H; Zhao L; Feng L; Li A; Zhang H; Ma Z; Li G
Exp Eye Res; 2016 May; 146():154-162. PubMed ID: 26971461
[TBL] [Abstract][Full Text] [Related]
25. Optical coherence tomographic findings of crystal deposits in the lens and cornea in Bietti crystalline corneoretinopathy associated with mutation in the CYP4V2 gene.
Chung JK; Shin JH; Jeon BR; Ki CS; Park TK
Jpn J Ophthalmol; 2013 Sep; 57(5):447-50. PubMed ID: 23793346
[TBL] [Abstract][Full Text] [Related]
26. Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization.
Fuerst NM; Serrano L; Han G; Morgan JI; Maguire AM; Leroy BP; Kim BJ; Aleman TS
Ophthalmic Genet; 2016 Dec; 37(4):445-452. PubMed ID: 27028354
[TBL] [Abstract][Full Text] [Related]
27. Molecular screening of the CYP4V2 gene in Bietti crystalline dystrophy that is associated with choroidal neovascularization.
Mamatha G; Umashankar V; Kasinathan N; Krishnan T; Sathyabaarathi R; Karthiyayini T; Amali J; Rao C; Madhavan J
Mol Vis; 2011; 17():1970-7. PubMed ID: 21850171
[TBL] [Abstract][Full Text] [Related]
28. CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.
Nakano M; Kelly EJ; Wiek C; Hanenberg H; Rettie AE
Mol Pharmacol; 2012 Oct; 82(4):679-86. PubMed ID: 22772592
[TBL] [Abstract][Full Text] [Related]
29. Optical coherence tomography angiography in Bietti crystalline dystrophy.
Montemagni M; Arrigo A; Battaglia Parodi M; Bianco L; Antropoli A; Malegori A; Bandello F; Tranfa F; Costagliola C
Eur J Ophthalmol; 2023 Nov; 33(6):NP1-NP5. PubMed ID: 36457241
[TBL] [Abstract][Full Text] [Related]
30. Observation of the characteristics of the natural course of Bietti crystalline dystrophy by fundus fluorescein angiography.
Zhang S; Wang L; Liu Z; Sun H; Li Q; Xing C; Xiao Z; Peng X
BMC Ophthalmol; 2021 May; 21(1):239. PubMed ID: 34049507
[TBL] [Abstract][Full Text] [Related]
31. A Novel Compound Heterozygous Mutation in the CYP4V2 Gene in a Japanese Patient with Bietti's Crystalline Corneoretinal Dystrophy.
Yokoi Y; Sato K; Aoyagi H; Takahashi Y; Yamagami M; Nakazawa M
Case Rep Ophthalmol; 2011 Sep; 2(3):296-301. PubMed ID: 22087103
[TBL] [Abstract][Full Text] [Related]
32. An In-Depth Single-Gene Worldwide Carrier Frequency and Genetic Prevalence Analysis of CYP4V2 as the Cause of Bietti Crystalline Dystrophy.
Hanany M; Yang RR; Lam CM; Beryozkin A; Sundaresan Y; Sharon D
Transl Vis Sci Technol; 2023 Feb; 12(2):27. PubMed ID: 36795063
[TBL] [Abstract][Full Text] [Related]
33. CHOROIDAL AND RETINAL ATROPHY OF BIETTI CRYSTALLINE DYSTROPHY PATIENTS WITH CYP4V2 MUTATIONS COMPARED TO RETINITIS PIGMENTOSA PATIENTS WITH EYS MUTATIONS.
Miyata M; Hata M; Ooto S; Ogino K; Gotoh N; Morooka S; Hasegawa T; Hirashima T; Sugahara M; Kuroda Y; Yamashiro K; Yoshimura N
Retina; 2017 Jun; 37(6):1193-1202. PubMed ID: 27658286
[TBL] [Abstract][Full Text] [Related]
34. PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti's Crystalline Dystrophy.
Zhang Z; Yan B; Gao F; Li Q; Meng X; Chen P; Zhou L; Deng W; Li C; Xu W; Han S; Feng H; Li Y; Chen J; Yin Z; Liao C; Tse HF; Xu A; Lian Q
Mol Ther; 2020 Dec; 28(12):2642-2661. PubMed ID: 32755565
[TBL] [Abstract][Full Text] [Related]
35. Novel insights into the molecular pathogenesis of CYP4V2-associated Bietti's retinal dystrophy.
Astuti GD; Sun V; Bauwens M; Zobor D; Leroy BP; Omar A; Jurklies B; Lopez I; Ren H; Yazar V; Hamel C; Kellner U; Wissinger B; Kohl S; De Baere E; Collin RW; Koenekoop RK
Mol Genet Genomic Med; 2015 Jan; 3(1):14-29. PubMed ID: 25629076
[TBL] [Abstract][Full Text] [Related]
36. Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes.
Hata M; Ikeda HO; Iwai S; Iida Y; Gotoh N; Asaka I; Ikeda K; Isobe Y; Hori A; Nakagawa S; Yamato S; Arita M; Yoshimura N; Tsujikawa A
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3936-3941. PubMed ID: 29581279
[TBL] [Abstract][Full Text] [Related]
37. Multimodal Imaging for Differential Diagnosis of Bietti Crystalline Dystrophy.
Oishi A; Oishi M; Miyata M; Hirashima T; Hasegawa T; Numa S; Tsujikawa A
Ophthalmol Retina; 2018 Oct; 2(10):1071-1077. PubMed ID: 31047497
[TBL] [Abstract][Full Text] [Related]
38. New compound heterozygous CYP4V2 mutations in bietti crystalline corneoretinal dystrophy.
Wang T; Chen Q; Yao X; Kuang L; Gan R; Wang J; Yan X
Gene; 2021 Jul; 790():145698. PubMed ID: 33964374
[TBL] [Abstract][Full Text] [Related]
39. OUTER RETINAL TUBULATION IN BIETTI CRYSTALLINE DYSTROPHY ASSOCIATED WITH THE RETINAL PIGMENT EPITHELIUM ATROPHY.
Wang Y; Chen J; Sun J; Li T; Yu S; Gong Y; Yu Y; Wan X; Jia H; Wu J; Yuan F; Shen X; Wang Z; Qiao T; Wu Q; Xu Y; Wang Z; Yang C; Qu J; Chen J; Sun X;
Retina; 2023 Apr; 43(4):659-669. PubMed ID: 36729610
[TBL] [Abstract][Full Text] [Related]
40. Expanding the Phenotypic and Genotypic Spectrum of Bietti Crystalline Dystrophy.
da Palma MM; Motta FL; Salles MV; Texeira CHM; Gomes AV; Casaroli-Marano R; Sallum JMF
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34068831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
